About SYMBIOTEC PHARMALAB LIMITED

Symbiotec Pharmalab IPO is a book build issue of Rs 1,757.00 crores. The issue is a combination of fresh issue of 0.15 crore shares aggregating to Rs 150.00 crores and offer for sale of 1.63 crore shares aggregating to Rs 1,607.00 crores.

Symbiotec Pharmalab IPO opens for subscription on Aug 24, 2026 and closes on Aug 27, 2026. The allotment for the Symbiotec Pharmalab IPO is expected to be finalized on Aug 28, 2026. Symbiotec Pharmalab IPO will list on NSE and BSE with a tentative listing date fixed as Sep 1, 2026.

Symbiotec Pharmalab IPO is set issue price band at Rs 938 to Rs 988 per share. The lot size for an application is 15 shares. The minimum amount of investment required by an individual investor (retail) is ?14,820 (15 shares) (based on upper price).

JM Financial Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.

SYMBIOTEC PHARMALAB LIMITED Timeline

Issue open date	24 Aug 2026 10 AM
Issue close date	27 Aug 2026 5 PM
Allotment finalization	28 Aug 2026
Refund initiation	31 Aug 2026
Share credit	31 Aug 2026
Listing date	01 Sep 2026

Documents

• Download Prospectus